Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1997-06-25
2000-06-20
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
424 92, 4352351, A61K 39155, C12N 701
Patent
active
060775149
ABSTRACT:
Attenuated respiratory syncytial viruses (RSV) and in particular temperature sensitive RSV are provided. The viruses of the present invention may be used in pharmaceutical compositions such as vaccines. Methods of making and using such pharmaceutical compositions are also provided.
REFERENCES:
patent: 4122167 (1978-10-01), Buynak et al.
patent: 4800078 (1989-01-01), Prince et al.
patent: 5223254 (1993-06-01), Paradiso et al.
Ambrose, M.W. et al., "Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton rats," Vaccine 9:505-511 (1991).
Anderson, L.J. et al., "Antigenic Characterization of Respiratory Syncytial Virus Strains with Monoclonal Antibodies," J. Inf. Dis. 151:626-633 (1985).
Anderson, L.J. et al., "Multicenter Study of Strains of Respiratory Syncytial Virus," J. Inf. Dis. 163:687-692 (1991).
Belshe, et al., "Evaluation of a Live Attenuated cold-Adapted Parainfluenza Virus Type 3 Vaccine in Children," Journal of Clinical Microbiology 30(8):2064-2070 (1992).
Brideau, et al., "Protection of cotton rats against human parainfluenza virus type 3 by vaccination with a chimeric FHN subunit glycoprotein," Journal of General Virology 74:471-477 (1993).
Chanock, et al., "Serious Respiratory Tract Disease Caused by Respiratory Syncytial Virus: Prospects for Improved Therapy and Effective Immunization," Pediatrics 90(1):137-143 (1992).
Cherrie, et al., "Human Cytotoxic T Cells Stimulated by Antigen on Dendritic Cells Recognize the N, SH, F, M, 22K and 1b Proteins of Respiratory Syncytial Virus," Journal of Virology 66(4):2102-2110 (1992).
Chin, J. et al., "Field Evaluation Of A Respiratory Syncytial Virus Vaccine And A trivalent Parainfluenza Virus Vaccine In A Pediatric Population," Am. J. Epidemiol. 89:449-463 (1969).
Clements, M.L. et al., "Evaluation of Bovine, Cold-Adapted Human, and Wild-Type Human Parainfluenza Type 3 Viruses in Adult Volunteers and in Chimpanzees," J. Clin. Microbiol. 29:1175-1185 (1991).
Connors, M. et al., "Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV," Vaccine 10(7):475-484 (1992).
Connors, M. et al., "Pulmonary Histopathology Induced by Respiratory Syncytial Virus (RSV) Challenge of Formalin-Inactivated RSV-Immunized BALB/c Mice Is Abrogated by Depletion of CD4.sup.+ T Cells," Journal of Virology 66(12):7444-7451 (1992).
Connors, M. et al., "Enhanced Pulmonary Histopathology Induced by Respiratory Syncytial Virus (RSV) Challenge of Formalin-Induced RSV-Immunized BALB/c Mice Is Abrogated by Depletion of Interleukin-4 (IL-4) and IL-10," Journal of Virology 68(8):5321-5325 (1994).
Ebata, S.N. et al., "Function and immunogenicity of human parainfluenza virus 3 glycoproteins expressed by recombinant adenoviruses," Virus Research 24:21-33 (1992).
Edwards, K.M. et al., "Safety and Immunogenicity of Live Attenuated Cold-Adapted Influenza B/Ann Arbor/1/86 Reassortant Virus Vaccine in Infants and Children," J. Inf. Dis. 163:740-745 (1991).
Ewasyshyn, M. et al., "Comparative analysis of the immunostimulatory properties of different adjuvants on the immunogenicity of a prototype parainfluenza virus type 3 subunit vaccine," Vaccine 10(6):412-420 (1992).
Fulginiti, V.A. et al., "Respiratory Virus Immunization," Am. J. Epidemiol. 89:435-448 (1969).
Glezen, W.P. et al., "Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level," J. Ped. 98(5):708-715 (1981).
Glezen, W.P. et al., "Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus," Am. J. Dis. Child. 140:543-546 (1986).
Glezen, et al., Appendix N. Prospects For Immunizing Against Respiratory Syncytial Virus, pp. 397-409.
Gupta, A. et al., "Restoration of Suppressor T-Cell Functions in Children With AIDS Following Intravenous Gamma Globulin Treatment," AJDC 140:143-146 (1986).
Hall, S.L. et al., "Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys," Virus Research 22:173-184 (1992).
Hall, C.B. et al., "Immunity to and Frequency of Reinfection with Respiratory Syncytial Virus," J. Inf. Dis. 163:693-698 (1991).
Hall, et al., "A Cold-Adapted Mutant of Parainfluenza Virus Type 3 Is Attenuated and Protective in Chimpanzees" Journal Infectious Disease 167:958-962 (1993).
Hall, S.L. et al., "Protection of cotton rats by immunization with the human parainfluenza virus type 3 fusion (F) glycoprotein expressed on the surface of insect cells infected with a recombinant baculovirus," Vaccine 9:659-667 (1991).
Henderson, F.W. et al., "Respiratory-Syncytial-Virus Infections, Reinfections And Immunity," N. Eng. J. Med. 300:530-534 (1979).
Jensen, et al., "Immunization Against Parainfluenza Infections," Department of Biologics Research, Chas. Pfizer & Co., Inc., 89:216-226 (Dec. 1961).
Kapikian, A.Z. et al., "An Epidemiologic Study Of Altered Clinical Reactivity To Respiratory Syncytial (RS) Virus Infection In Children Previously Vaccinated With An Inactivated RS Virus Vaccine," Am. J. Epidemiol. 89:405-421 (1968).
Kasel, J.A. et al., "Acquisition Of Serum Antibodies To Specific Viral Glycoproteins Of Parainfluenza Virus 3 In Children," Journal of Virology 52(3):828-832 (1984).
Kasel, et al., "Relation of Serum Antibody to Glycoproteins of Respiratory Syncytial Virus with Immunity to Infection in Children," Vir. Immunol. 1:199-205 (1987/88).
Kim, H.W. et al., "Respiratory Synctial Virus disease In Infants Despite Prior Administration Of Antigenic Inactivated Vaccine," Am. J. Epidemiol. 89:422-434 (1969).
Kim, H.W. et al., "Clinical And Immunological Response Of Infants And Children To Administration Of Low-Temperature Adapted Respiratory Syncytial Virus," Pediatrics 48:745-755 (1971).
Kim et al., "Safety And Antigenicity Of Temperature Sensitive (TS) Mutant Respiratory Syncytial Virus (RSV) In Infants And Children," Pediatrics 52:56-63 (1973).
Lamprecht, C.L. et al., "Role Of Maternal Antibody In Pneumonia And Bronchiolitis Due To Respiratory Syncytial Virus," J. Inf. Dis. 134:211-217 (1976).
Lehman, et al., "Comparison of soluble and secreted forms of human parainfluenza virus type 3 glycoproteins expressed from mammalian and insect cells as subunit vaccines," Journal of General Virology 74:459-469 (1993).
Maassab, H.F. et al., "Development and characterization of cold-adapted viruses for use as live virus vaccines," Vaccine 3:355-369 (1985).
Maniatis, T. et al., Molecular Cloning: a Laboratory Manual, Cold Springs Harbor Laboratory, Cold Springs, N.Y. (1982) at pp. 387-389.
McIntosh et al., Virology, Second Edition, 91990, Chapter 38, Respiratory Synctial Virus, pp. 1045-1072.
Mufson, M.A. et al., "Two Distinct Subtypes of Human Respiratory Syncytial Virus," J. Gen. Virol. 66:2111-2124 (1985).
Murphy, B.R. et al., "Formalin-Inactivated Respiratory Syncytial Virus Vaccine Induces Antibodies To The Fusion Glycoprotein That Are Deficient In Fusion-Inhibiting Activity," J. Clin. Microbiol. 26(8):1595-1597 (1987).
Murphy, B.R. et al., "Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses," Virus Research (Review Article) 11:1-16 (1988).
Obrosova-Serova, N.P. et al., "Evaluation in children of cold-adapted influenza B live attenuated intranasal vaccine prepared by reassortment between wild-type B/Ann Arbor/1/86 and cold-adapted B/Leningrad/14/55 viruses," Vaccine 8:57-60 (1990).
Prince, G.A. et al., "Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat," Virus Res. 3:193-206 (1985).
Ray, R. et al., "Microencapsulated Human Parainfluenza Virus Induces a Protective Immune Response," The Journal of Infectious Diseases 167:752-755 (1993).
Ray, R. et al., "Glycoproteins of Human Parainfluenza Virus Type 3: Characterization and Evaluation as a Subunit Vaccine," The Journal of Infectious Diseases 152(6):1219-1230
Herlocher M. Louise
Maassab Hunein F.
Mosher Mary E.
Salimi Ali R.
Smith DeAnn F.
The Regents of the University of Michigan
LandOfFree
Attenuated respiratory syncytial virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Attenuated respiratory syncytial virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Attenuated respiratory syncytial virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1849880